Delivery Order SPE2DB22D3301-SPE2DB24FZ0YA
Award Date
7/18/24
Potential Completion Date
7/19/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,318.43 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of July 18, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,528.04 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 8 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,338.11 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets, with a period of performance through July 3, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,448.05, is for the delivery of candesartan cilexetil 16 mg tablets. The contract is a firm fixed-price delivery order with a completion date of November 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $5,666.28 and a completion date of January 8, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with any set-aside requirements, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $6,933.79 and a completion date of September 11, 2024. The award is for the supply of Candesartan Cilexetil 16 mg tablets in 90-count packages. This contract is not set aside for any specific business type. Amerisourcebergen holds significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $18,160.26. The contract provides Candesartan Cilexetil 16 mg tablets in 90-count packages, with a period of performance ending on July 10, 2025. This award is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,826,834 units of the prescription drug Candesartan Cilexetil 16 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $15,702.81 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which does not have a set-aside designation. This contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,839.45, is a delivery order for the supply of Candesartan Cilexetil 8 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside and was awarded as part of Amerisourcebergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,347.24 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...